Lupin Limited has informed the Exchange regarding a press release dated July 03, 2023, titled "Lupin Receives Approval from U.S. FDA for Cyanocobalamin Nasal Spray.".
Lupin Limited has informed the Exchange regarding a press release dated July 03, 2023, titled "Lupin Receives Approval from U.S. FDA for Cyanocobalamin Nasal Spray.".